LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

Search

ACADIA Pharmaceuticals Inc

Затворен

Сектор Здравеопазване

17.79 0.79

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

17.68

Максимум

17.83

Ключови измерители

By Trading Economics

Приходи

-29M

17M

Продажби

-25M

206M

EPS

0.1

Марж на печалбата

8.044

Служители

597

EBITDA

-16M

21M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+54.19 upside

Дивиденти

By Dow Jones

Следващи печалби

31.07.2024 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-6.6M

2.7B

Предишно отваряне

17

Предишно затваряне

17.79

Настроения в новините

By Acuity

100%

0%

349 / 369 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

ACADIA Pharmaceuticals Inc Графика

Свързани новини

12.07.2024 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110 Million

12.07.2024 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Lundin Mining Approaches BHP to Buy Copper Miner Filo, Bloomberg Reports

12.07.2024 г., 19:57 ч. UTC

Значими двигатели на пазара

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

12.07.2024 г., 18:13 ч. UTC

Топ новини

Elon Musk's X Found in Breach of EU Digital-Content Law -- 2nd Update

12.07.2024 г., 23:29 ч. UTC

Придобивния, сливания и поглъщания

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

12.07.2024 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

Pactiv Evergreen Sells Paper Mill, Extrusion Facility to Suzano for $110M

12.07.2024 г., 21:03 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

The Score: Microsoft, Delta Air Lines, Wells Fargo and More Stocks That Defined the Week -- WSJ

12.07.2024 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

12.07.2024 г., 20:41 ч. UTC

Топ новини

Dow Rises With Investors Putting Rate Cut in Sight -- WSJ

12.07.2024 г., 20:38 ч. UTC

Придобивния, сливания и поглъщания

Ansys: Synopsys Submits Notification of Transaction to China Regulator for Purchase of Ansys

12.07.2024 г., 20:26 ч. UTC

Топ новини
Печалби

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12.07.2024 г., 20:19 ч. UTC

Печалби

These Stocks Moved the Most Today: Tesla, Wells Fargo, JPMorgan, BNY, Nvidia, and More -- Barrons.com

12.07.2024 г., 19:26 ч. UTC

Печалби

Correction to Big Banks Continue to Feel Pressure From Higher Rates Article -- WSJ

12.07.2024 г., 19:07 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Snap 3-Day Losing Streak -- Market Talk

12.07.2024 г., 17:52 ч. UTC

Топ новини
Печалби

Big Banks Continue to Feel Pressure From Higher Rates -- 3rd Update

12.07.2024 г., 17:34 ч. UTC

Пазарно говорене

Gold Takes Pause After Surge -- Market Talk

12.07.2024 г., 17:31 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Down By 1 to 478 -- Market Talk

12.07.2024 г., 17:22 ч. UTC

Пазарно говорене

Private-Capital Investing For Solar Developers Dropped in 1H -- Market Talk

12.07.2024 г., 17:01 ч. UTC

Топ новини

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- 2nd Update

12.07.2024 г., 16:45 ч. UTC

Пазарно говорене

Nike's Corporate Plan Step in Right Direction, but Challenges Mount -- Market Talk

12.07.2024 г., 16:44 ч. UTC

Пазарно говорене

Estée Lauder CFO Change Needs to Offer Fresh Perspective -- Market Talk

12.07.2024 г., 16:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

12.07.2024 г., 16:08 ч. UTC

Пазарно говорене

Gold Futures Pare Some Gains But Hold Above $2,400 on Soft Inflation Data -- Market Talk

12.07.2024 г., 16:02 ч. UTC

Топ новини

Big Banks Continue to Feel Pressure From Higher Rates -- 2nd Update

12.07.2024 г., 15:45 ч. UTC

Пазарно говорене

KC Fed Seeing Green Shoots in Energy Activity -- Market Talk

12.07.2024 г., 15:43 ч. UTC

Пазарно говорене

Bank of Canada Likely Thrilled With Housing-Market Data -- Market Talk

12.07.2024 г., 15:39 ч. UTC

Пазарно говорене

Canada Home-Sales Activity 'Subdued' Despite Rise in June -- Market Talk

12.07.2024 г., 15:36 ч. UTC

Топ новини

Berkshire Hathaway Stock Hits Record. Warren Buffett's Stake at $133 Billion. -- Barrons.com

12.07.2024 г., 15:32 ч. UTC

Топ новини

AT&T Says Hacker Stole Cell, Text Data on Nearly All Its Wireless Customers -- Update

12.07.2024 г., 15:32 ч. UTC

Пазарно говорене

Boeing Profits Lost In Space -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

ACADIA Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

54.19% нагоре

12-месечна прогноза

Среден 27.4 USD  54.19%

Висок 39 USD

Нисък 17 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за ACADIA Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

11

Купи

4

Задържане

0

Продай

Техническа оценка

By Trading Central

15.89 / 17.96Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

$

Относно ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system disorders. The Company's product pipeline includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist/antagonist, preferentially targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors. Trofinetide is a synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome. ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).